Syndecan-1 knockdown inhibits glioma cell proliferation and invasion by deregulating a c-src/FAK-associated signaling pathway

Recent studies have shown that increased syndecan-1 (SDC1) expression in human glioma is associated with higher tumor grades and poor prognoses, but its oncogenic functions and the underlying molecular mechanisms remain unknown. Here, we examined SDC1 expression in datasets from The Cancer Genome At...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Shuang, Zhong, Dong, Xiao, Yao, Wang, Bing, Wang, Wentao, Zhang, Fu’an, Huang, Haoyang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5522338/
https://www.ncbi.nlm.nih.gov/pubmed/28422726
http://dx.doi.org/10.18632/oncotarget.16733

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5522338/
https://www.ncbi.nlm.nih.gov/pubmed/28422726
http://dx.doi.org/10.18632/oncotarget.16733

Ejemplares similares